Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 43

    1.

    Safety and Pharmacokinetics of Repeat-Dose Micafungin in Young Infants.

    Benjamin DK Jr, Smith PB, Arrieta A, Castro L, Sánchez PJ, Kaufman D, Arnold LJ, Kovanda LL, Sawamoto T, Buell DN, Hope WW, Walsh TJ.

    Clin Pharmacol Ther. 2009 Nov 4. [Epub ahead of print]PMID: 19890251 [PubMed - as supplied by publisher]Related articles

    2.

    Pharmacokinetics of an elevated dosage of micafungin in premature neonates.

    Smith PB, Walsh TJ, Hope W, Arrieta A, Takada A, Kovanda LL, Kearns GL, Kaufman D, Sawamoto T, Buell DN, Benjamin DK Jr.

    Pediatr Infect Dis J. 2009 May;28(5):412-5.PMID: 19319022 [PubMed - indexed for MEDLINE]Related articles

    3.

    Population pharmacokinetics of micafungin in adult patients.

    Gumbo T, Hiemenz J, Ma L, Keirns JJ, Buell DN, Drusano GL.

    Diagn Microbiol Infect Dis. 2008 Mar;60(3):329-31. Epub 2007 Nov 19.PMID: 18024052 [PubMed - indexed for MEDLINE]Related articles

    4.

    Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis.

    Pappas PG, Rotstein CM, Betts RF, Nucci M, Talwar D, De Waele JJ, Vazquez JA, Dupont BF, Horn DL, Ostrosky-Zeichner L, Reboli AC, Suh B, Digumarti R, Wu C, Kovanda LL, Arnold LJ, Buell DN.

    Clin Infect Dis. 2007 Oct 1;45(7):883-93. Epub 2007 Aug 29. Erratum in: Clin Infect Dis. 2008 Jul 15;47(2):302. PMID: 17806055 [PubMed - indexed for MEDLINE]Related articles

    5.

    Population pharmacokinetics of micafungin in pediatric patients and implications for antifungal dosing.

    Hope WW, Seibel NL, Schwartz CL, Arrieta A, Flynn P, Shad A, Albano E, Keirns JJ, Buell DN, Gumbo T, Drusano GL, Walsh TJ.

    Antimicrob Agents Chemother. 2007 Oct;51(10):3714-9. Epub 2007 Jul 16.PMID: 17638696 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    The pharmacokinetics and safety of micafungin, a novel echinocandin, in premature infants.

    Heresi GP, Gerstmann DR, Reed MD, van den Anker JN, Blumer JL, Kovanda L, Keirns JJ, Buell DN, Kearns GL.

    Pediatr Infect Dis J. 2006 Dec;25(12):1110-5.PMID: 17133155 [PubMed - indexed for MEDLINE]Related articles

    7.

    Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis.

    Denning DW, Marr KA, Lau WM, Facklam DP, Ratanatharathorn V, Becker C, Ullmann AJ, Seibel NL, Flynn PM, van Burik JA, Buell DN, Patterson TF.

    J Infect. 2006 Nov;53(5):337-49. Epub 2006 May 6.PMID: 16678903 [PubMed - indexed for MEDLINE]Related articles

    8.

    International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia.

    Ostrosky-Zeichner L, Kontoyiannis D, Raffalli J, Mullane KM, Vazquez J, Anaissie EJ, Lipton J, Jacobs P, van Rensburg JH, Rex JH, Lau W, Facklam D, Buell DN.

    Eur J Clin Microbiol Infect Dis. 2005 Oct;24(10):654-61. Erratum in: Eur J Clin Microbiol Infect Dis. 2006 Jan;25(1):69. PMID: 16261306 [PubMed - indexed for MEDLINE]Related articles

    9.

    Safety, tolerability, and pharmacokinetics of Micafungin (FK463) in febrile neutropenic pediatric patients.

    Seibel NL, Schwartz C, Arrieta A, Flynn P, Shad A, Albano E, Keirns J, Lau WM, Facklam DP, Buell DN, Walsh TJ.

    Antimicrob Agents Chemother. 2005 Aug;49(8):3317-24.PMID: 16048942 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Plasma protein binding of amphotericin B and pharmacokinetics of bound versus unbound amphotericin B after administration of intravenous liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate.

    Bekersky I, Fielding RM, Dressler DE, Lee JW, Buell DN, Walsh TJ.

    Antimicrob Agents Chemother. 2002 Mar;46(3):834-40.PMID: 11850269 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Pharmacokinetics, excretion, and mass balance of liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate in humans.

    Bekersky I, Fielding RM, Dressler DE, Lee JW, Buell DN, Walsh TJ.

    Antimicrob Agents Chemother. 2002 Mar;46(3):828-33.PMID: 11850268 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study.

    Walsh TJ, Goodman JL, Pappas P, Bekersky I, Buell DN, Roden M, Barrett J, Anaissie EJ.

    Antimicrob Agents Chemother. 2001 Dec;45(12):3487-96.PMID: 11709329 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Pharmacokinetics, excretion, and mass balance of 14C after administration of 14C-cholesterol-labeled AmBisome to healthy volunteers.

    Bekersky I, Fielding RM, Dressler DE, Kline S, Buell DN, Walsh TJ.

    J Clin Pharmacol. 2001 Sep;41(9):963-71.PMID: 11549101 [PubMed - indexed for MEDLINE]Related articles

    14.

    Tacrolimus vs. cyclosporine immunosuppression: results in advanced-stage disease compared with historical controls treated exclusively with cyclosporine.

    Horowitz MM, Przepiorka D, Bartels P, Buell DN, Zhang MJ, Fitzsimmons WE, Erdman J, Huang C, Hodosh E, Maher R, Wingard JR.

    Biol Blood Marrow Transplant. 1999;5(3):180-6.PMID: 10392964 [PubMed - indexed for MEDLINE]Related articles

    15.

    Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation.

    Ratanatharathorn V, Nash RA, Przepiorka D, Devine SM, Klein JL, Weisdorf D, Fay JW, Nademanee A, Antin JH, Christiansen NP, van der Jagt R, Herzig RH, Litzow MR, Wolff SN, Longo WL, Petersen FB, Karanes C, Avalos B, Storb R, Buell DN, Maher RM, Fitzsimmons WE, Wingard JR.

    Blood. 1998 Oct 1;92(7):2303-14.PMID: 9746768 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Fluconazole versus amphotericin B in the treatment of esophageal candidiasis in cancer patients.

    Lake DE, Kunzweiler J, Beer M, Buell DN, Islam MZ.

    Chemotherapy. 1996 Jul-Aug;42(4):308-14.PMID: 8804799 [PubMed - indexed for MEDLINE]Related articles

    17.

    Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial.

    Winston DJ, Chandrasekar PH, Lazarus HM, Goodman JL, Silber JL, Horowitz H, Shadduck RK, Rosenfeld CS, Ho WG, Islam MZ, Buell DN.

    Ann Intern Med. 1993 Apr 1;118(7):495-503.PMID: 8442620 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Potential hazards of selenium as a chemopreventive agent.

    Buell DN.

    Semin Oncol. 1983 Sep;10(3):311-21. Review.PMID: 6364358 [PubMed - indexed for MEDLINE]Related articles

    19.

    Clinical Oncology Program: a community cancer control model.

    Dugan WM Jr, Minnick DJ, Wood JR, Dailey KS, Jansen MA, Lohrman RG, Buell DN.

    CA Cancer J Clin. 1979 Sep-Oct;29(5):300-5.PMID: 113056 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Supportive care: twenty years of progress.

    Jaffe N, Buell DN.

    Pediatr Ann. 1978 Jul;7(7):508-11. No abstract available. PMID: 97615 [PubMed - indexed for MEDLINE]Related articles

    21.

    Viral reverse transcriptase suppression associated with erythroid differentiation of Friend leukemia cells.

    Ebert PS, Buell DN.

    J Natl Cancer Inst. 1977 Mar;58(3):635-40.PMID: 65477 [PubMed - indexed for MEDLINE]Related articles

    22.

    Cell cycle and morphological changes during growth and differentiation of a rat basophilic leukemia cell line.

    Buell DN, Fowlkes BJ, Metzher H, Isersky C.

    Cancer Res. 1976 Sep;36(9 pt.1):3131-7.PMID: 975078 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Insulin binding of acute lymphocytic leukemia cells.

    Esber EC, Buell DN, Leikin SL.

    Blood. 1976 Jul;48(1):33-9.PMID: 1084767 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Erythroid differentiation in cultured Friend leukemia cells treated with metabolic inhibitors.

    Ebert PS, Wars I, Buell DN.

    Cancer Res. 1976 May;36(5):1809-13.PMID: 57826 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Cell cycle-associated changes in receptors for IgE during growth and differentiation of a rat basophilic leukemia cell line.

    Isersky C, Metzger H, Buell DN.

    J Exp Med. 1975 May 1;141(5):1147-62.PMID: 1168692 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Autologous human B and T lymphoblastoid cell lines.

    Royston I, Smith RW, Buell DN, Huang ES, Pagano JS.

    Nature. 1974 Oct 25;251(5477):745-6. No abstract available. PMID: 4372538 [PubMed - indexed for MEDLINE]Related articles

    27.

    IgD on cell membranes of human lymphoid cell lines with multiple immunoglobulin classes.

    van Boxel JA, Buell DN.

    Nature. 1974 Oct 4;251(5474):443-4. No abstract available. PMID: 4608784 [PubMed - indexed for MEDLINE]Related articles

    28.

    Xeroderma pigmentosum long-term lymphoid lines with increased ultraviolet sensitivity.

    Andrews AD, Robbins JH, Kraemer KH, Buell DN.

    J Natl Cancer Inst. 1974 Sep;53(3):691-3. No abstract available. PMID: 4416919 [PubMed - indexed for MEDLINE]Related articles

    29.

    Bone-resorbing activity in supernatants from lymphoid cell lines.

    Mundy GR, Luben RA, Raisz LG, Oppenheim JJ, Buell DN.

    N Engl J Med. 1974 Apr 18;290(16):867-71. No abstract available. PMID: 4816960 [PubMed - indexed for MEDLINE]Related articles

    30.

    Insulin-dependent regulation of insulin receptor concentrations: a direct demonstration in cell culture.

    Gavin JR 3rd, Roth J, Neville DM Jr, de Meyts P, Buell DN.

    Proc Natl Acad Sci U S A. 1974 Jan;71(1):84-8.PMID: 4359334 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Cytotoxicity mediated by human lymphocyte-dependent antibody in a rapid assay with adherent target cells.

    Yust I, Wunderlich JR, Mann DL, Buell DN.

    J Immunol. 1973 Jun;110(6):1672-81. No abstract available. PMID: 4712926 [PubMed - indexed for MEDLINE]Related articles

    32.

    Characteristics of the human lymphocyte insulin receptor.

    Gavin JR 3rd, Gorden P, Roth J, Archer JA, Buell DN.

    J Biol Chem. 1973 Mar 25;248(6):2202-7. No abstract available. PMID: 4347860 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    An antigenic marker for human thymic lymphocytes.

    Smith RW, Terry WD, Buell DN, Sell KW.

    J Immunol. 1973 Mar;110(3):884-7. No abstract available. PMID: 4540134 [PubMed - indexed for MEDLINE]Related articles

    34.

    Separation of human lymphoid cells into G 1 , S, and G 2 cell cycle populations by use of a velocity sedimentation technique.

    Everson LK, Buell DN, Rogentine GN Jr.

    J Exp Med. 1973 Feb 1;137(2):343-58. No abstract available. PMID: 4568300 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Preparation of solubilized insulin receptors from human lymphocytes.

    Gavin JR 3rd, Buell DN, Roth J.

    Biochem Biophys Res Commun. 1972 Nov 1;49(3):870-6. No abstract available. PMID: 4344690 [PubMed - indexed for MEDLINE]Related articles

    36.

    Water-soluble insulin receptors from human lymphocytes.

    Gavin JR 3rd, Buell DN, Roth J.

    Science. 1972 Oct 13;178(57):168-9.PMID: 4342623 [PubMed - indexed for MEDLINE]Related articles

    37.

    Proliferation and differentiation of lymphoid cells: studies with human lymphoid cell lines and immunoglobulin synthesis.

    Fahey JL, Buell DN, Sox HC.

    Ann N Y Acad Sci. 1971 Dec 31;190:221-34. No abstract available. PMID: 5290016 [PubMed - indexed for MEDLINE]Related articles

    38.

    Multiple myeloma with IgG (lambda) and IgA (lambda) serum M-components: immunohistologic studies.

    Rudders RA, Buell DN, Pisciotta AV.

    J Lab Clin Med. 1971 Nov;78(5):847-8. No abstract available. PMID: 5128899 [PubMed - indexed for MEDLINE]Related articles

    39.

    Further characterization of the WI-L1 and WI-L2 lymphoblastoid lines.

    Levy JA, Buell DN, Creech C, Hirshaut Y, Silverberg H.

    J Natl Cancer Inst. 1971 Mar;46(3):647-54. No abstract available. PMID: 4323138 [PubMed - indexed for MEDLINE]Related articles

    40.

    Limited periods of gene expression in immunoglobulin-synthesizing cells.

    Buell DN, Fahey JL.

    Science. 1969 Jun 27;164(887):1524-5.PMID: 4182344 [PubMed - indexed for MEDLINE]Related articles

    41.

    Biosynthetic and structural studies of a heavy chain disease protein.

    Ein D, Buell DN, Fahey JL.

    J Clin Invest. 1969 Apr;48(4):785-93.PMID: 4180120 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    THE RELATIONSHIP OF GAMMA-1A GLOBULIN AND REAGIN IN CORD SERA.

    ALLANSMITH M, BUELL DN.

    J Allergy Clin Immunol. 1964 Jul-Aug;35:339-45. No abstract available. PMID: 14193186 [PubMed - indexed for MEDLINE]Related articles

    43.

    DEMONSTRATION OF GAMMA-2 GLOBULIN IN HUMAN SKIN.

    ALLANSMITH M, GOIHMAN-YAHR M, BUELL DN.

    J Allergy Clin Immunol. 1964 Jul-Aug;35:313-21. No abstract available. PMID: 14193183 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...